Resolution of Hairy Cell Leukemia Minimal Residual Disease by Both BRAF and Clone-Specific Real-Time Quantitative PCR (RQ-PCR) After Treatment with Moxetumomab Pasudotox

被引：0

作者：

Kreitman, Robert J. ^{[1
]}

Arons, Evgeny ^{[1
]}

Jeffrey, Sapolsky ^{[1
]}

Roth, Laura ^{[1
]}

Zhou, Hong ^{[1
]}

Stetler-Stevenson, Maryalice ^{[2
]}

Wilson, Wyndham H. ^{[3
]}

Raffeld, Mark ^{[2
]}

FitzGerald, David J. P. ^{[1
]}

Fei, Ji ^{[4
]}

Ibrahim, Ramy ^{[4
]}

Pastan, Ira ^{[1
]}

机构：

[1] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA

[2] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA

[3] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA

[4] MedImmune LLC, Gaithersburg, MD USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.2896.2896

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2896

引用

页数：2

共 50 条

[1] Durability of complete remission by moxetumomab pasudotox (HA22 or CAT-8015) assessed by clone-specific real-time quantitative PCR (RQ-PCR).
Kreitman, Robert J.
Arons, Evgeny
Sapolsky, Jeffrey
Roth, Laura
Zhou, Hong
Stetler-Stevenson, Maryalice
Wilson, Wyndham Hopkins
Raffeld, Mark
FitzGerald, David J. P.
Ji, Fei
Ibrahim, Ramy A.
Pastan, Ira
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[2] CLONE-SPECIFIC IGH PLASMIDS AS AN ALTERNATIVE STANDARD FOR ASSESSMENT OF MINIMAL RESIDUAL DISEASE BY REAL-TIME QUANTITATIVE PCR IN FOLLICULAR LYMPHOMA
Laubenstein, T.
Kneba, M.
Pott, C.
HAEMATOLOGICA, 2016, 101 : 480 - 481
[3] Quantitation of minimal residual disease (MRD) in TEL/AML1 positive patients during treatment by real-time quantitative RT-PCR (RQ-PCR)
Ballerini, P
Landman-Parker, J
Blaise, A
Laurendeau, I
Vidaud, M
Adam, M
Auvrignon, A
Leverger, G
Douay, L
Cayre, YE
Bièche, I
LEUKEMIA, 2001, 15 (12) : 2018 - 2018
[4] Minimal residual disease in childhood acute lymphoblastic leukemia: A comparative study of flow cytometry and quantitative real-time polymerase chain reaction (RQ-PCR)
Misra, AK
Sartor, M
Sutton, R
Venn, NC
Cross, S
Bradstock, K
Norris, M
Dalla-Pozza, L
BLOOD, 2004, 104 (11) : 209B - 209B
[5] Expression profiles of 'minimal residual disease' (MRD) markers for neuroblastoma in peripheral blood and its cell fractions by real-time quantitative PCIR (RQ-PCR)
Yalcin, B.
Zappeij, L.
van der Schoot, E.
Tytgat, G. A. M.
Gerritsen, A.
Dee, R.
Caron, H. N.
Versteeg, R.
EJC SUPPLEMENTS, 2005, 3 (02): : 359 - 360
[6] Assessment of minimal residual disease (MRD) by qualitative RT-PCR (Q-PCR) vs real-time quantitative RT-PCR (RQ-PCR) in a phase II study of acute promyelocytic leukemia (APL)
Gallagher, RE
Schachter-Tokarz, EL
Jones, DA
Estey, EH
BLOOD, 2005, 106 (11) : 912A - 912A
[7] Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction
Arons, E
Margulies, I
Sorbara, L
Raffeld, M
Stetler-Stevenson, M
Pastan, I
Kreitman, RJ
CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2804 - 2811
[8] Detection and monitoring of minimal residual disease by quantitative real-time PCR
Schüler, F
Dölken, G
CLINICA CHIMICA ACTA, 2006, 363 (1-2) : 147 - 156
[9] Real-time quantitative PCR (RQ-PCR) detection of minimal residual disease (MRD) by optimized WT1 assay to enhance risk stratification in acute myeloid leukemia (AML):: A European leukemia net study.
Cilloni, Daniela
Renneville, A.
Hermitte, F.
Hills, R. K.
Daly, S.
Jovanovic, J.
Gottardi, E.
Fava, M.
Schnittger, S.
Izzo, B.
Nomdedeu, J.
Van der Heijden, A.
Van der Velden, V.
Rohon, P.
Ommen, H.
Polak, J.
Jansen, J.
Preudhomme, C.
Saglio, G.
Grimwade, D.
BLOOD, 2007, 110 (11) : 167A - 167A
[10] Real-time quantitative PCR using hairpin-shaped clone-specific primers for minimal residual disease assessment in an animal model of human non-Hodgkin lymphoma
Gentilini, Fabio
Turba, Maria Elena
Calzolari, Claudia
Cinotti, Stefano
Forni, Monica
Zannoni, Augusta
MOLECULAR AND CELLULAR PROBES, 2010, 24 (01) : 6 - 14

← 1 2 3 4 5 →